Fresh Del Monte Produce: Q1 Earnings Insights

Fresh Del Monte Produce (NYSE:FDP) reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:15 AM.…

byBenzinga Insights

May 3, 2023

1 minute read

Fresh Del Monte Produce (NYSE:FDP) reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:15 AM.

Here’s what investors need to know about the announcement.

Earnings

Fresh Del Monte Produce missed estimated earnings by 6.78%, reporting an EPS of $0.55 versus an estimate of $0.59.

Revenue was down $8.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.49 which was followed by a 2.13% drop in the share price the next day.

Here’s a look at Fresh Del Monte Produce’s past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.04	0.09	0.79
EPS Actual	0.45	0.54	0.43	0.55
Revenue Estimate	1.03B	1.04B	1.15B	1.02B
Revenue Actual	1.04B	1.05B	1.21B	1.14B

To track all earnings releases for Fresh Del Monte Produce visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

F5 Analysts Boost Their Forecasts After Better-Than-Expected Q1 Results

By Avi Kapoor

January 30, 2:40 PM

F5, Inc. (NASDAQ: FFIV) posted better-than-expected results for its first quarter on Monday.

FFIV

Turquoise Hill Resources Q2 EPS $0.41 Beats $0.36 Estimate, Sales $402.04M Miss $411.87M Estimate

By Michael Horton

August 4, 5:25 PM

Turquoise Hill Resources (NYSE:TRQ) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.36 by 13.89 percent. This is a 14.58 percent decrease over earnings of $0.48 per share

TRQ

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets

By Jelena Martinovic

February 14, 11:03 AM

Medical cannabis company cbdMD has reported financial results for its first quarter of fiscal 2024. Operating loss improved to $1.1m compared to $4.1m for the same period in the previous year. Gross profit was flat at around $3.5m, while operating expenses were $4.6m, down from $7.6m in the previous year. Total net sales declined to $5.37m from almost $6m in the corresponding prior-year period. Direct-to-consumer net sales represented 82.3% of total net sales, a decrease from 90% in Q1 2023. On 31 December 2023, cbdMD had total working capital of roughly $1.4m compared to approximately $3.4m on 30 September, with cash on hand dropping to roughly $1.5m from $1.8m over the same period. The Charlotte-based company recently struck a securities purchase agreement with five institutional investors to fund the national rollout of its ATRx Labs functional mushroom products, as well as launching the hempMD and ATRx Labs brands.

YCBD